Psychopharmacological Treatment of Patients with HIV/AIDS

Ferrando, Stephen J.
May 2013
Psychiatric Annals;May2013, Vol. 43 Issue 5, p223
Academic Journal
The article discusses the psychopharmacological treatment of HIV/AIDS patients. Psychopharmacological treatment of HIV-infected patients is said to be complicated by several factors, including a broad differential diagnosis of psychiatric symptoms, abuse liability, and lethality in overdose for some classes of psychotropics. Treatment methods for psychiatric symptoms and disorders in HIV/AIDS are discussed.


Related Articles

  • Comparison of the Prophylactic Action of Flupenthixol with Placebo in Lithium Treated Manic-Depressive Patients. Esparon, J.; Kolloori, J.; Naylor, G. J.; Smith, A. M.; Hopwood, S. E. // British Journal of Psychiatry;Jun86, Vol. 148, p723 

    A double-blind cross-over trial of depot flupenthixol in recurrent manic depressive psychosis was carried out. All patients continued on lithium. Eleven patients completed the two-year trial. Flupenthixol appeared to have no prophylactic effect.

  • Ethical and pragmatic issues in the use of psychotropic agents in young children. Jensen, Peter S.; Jensen, P S // Canadian Journal of Psychiatry;Aug1998, Vol. 43 Issue 6, p585 

    Objective: To provide an overview of the knowledge base concerning the prescribing of psychotropic agents in young children with mental disorder and related mental health problems.Method: Relevant information is reviewed concerning the knowledge base available to inform...

  • HIV Giving Rise To Mental Illness.  // Day After;10/01/2013, Vol. 27 Issue 19, p43 

    The article discusses the release of a report by the World Health Organization (WHO) on mental disorder in India in 2013. WHO cited that mentally ill in India have nearly outnumbered the HIV+ patients in the country. Experts noted that all individuals with mental disorder and HIV are doubly...

  • Mental Health Concerns of HIV-Infected Gay and Bisexual Men Seeking Mental Health Services: An Observational Study. Berg, Michael B.; Mimiaga, Matthew J.; Safren, Steven A. // AIDS Patient Care & STDs;Nov2004, Vol. 18 Issue 11, p635 

    Addressing mental health concerns of HIV-positive individuals is an important component of providing quality HIV care. Mental health intake information from patients with HIV can be an important source of data to complement existing research on HIV and mental health because the intake...

  • NEUROCHEMICAL SELVES. Rose, Nikolas // Society;Nov/Dec2003, Vol. 41 Issue 1, p46 

    This article focuses on the development in the use of psychiatric drugs. By 1990, a fundamental shift had occurred in psychiatric thought and practice. More so in the development of psychiatric drugs. Nowadays, the fabrication and action of these drugs is conceived in terms of their impact on...

  • My mental health. Wells, Amanda // Mental Health Practice;Dec2004, Vol. 8 Issue 4, p22 

    Discusses the author's perception on the use of psychiatric drugs during psychiatric treatments. Pros and con of using psychiatric drugs; Names of the drugs used by the author during her drug treatment; Functionalism of these drugs.

  • Patient-Related Risks for Nonadherence to Antiretroviral Therapy among HIV-Infected Youth in the United States: A Study of Prevalence and Interactions. Rudy, Bret J.; Murphy, Debra A.; Harris, D. Robert; Muenz, Larry; Ellen, Jonathan // AIDS Patient Care & STDs;Mar2009, Vol. 23 Issue 3, p185 

    Adherence continues to be a major barrier to successful treatment with highly active antiretroviral therapy (HAART) for HIV-infected individuals. HIV-infected adolescents and young adults face a lifetime of treatment with HAART. Often, individuals who struggle with adherence to HAART face...

  • The Effect of Mental Illness, Substance Use, and Treatment for Depression on the Initiation of Highly Active Antiretroviral Therapy among HIV-Infected Individuals. Tegger, Mary K.; Crane, Heidi M.; Tapia, Kenneth A.; Uldall, Karina K.; Holte, Sarah E.; Kitahata, Mari M. // AIDS Patient Care & STDs;Mar2008, Vol. 22 Issue 3, p233 

    Information regarding the prevalence of mental illness and substance use among HIV-infected patients and the effect of these problems on HIV treatment is needed. We conducted an observational study of patients in the University of Washington (UW) HIV Cohort to determine prevalence rates for...

  • Psychosis in a 12-Year-Old HIVPositive Girl with an Increased Serum Concentration of Efavirenz. Lowenhaupt, Elizabeth A.; Matson, Kelly; Qureishi, Bushra; Saitoh, Akihiko; Pugatch, David // Clinical Infectious Diseases;11/15/2007, Vol. 45 Issue 10, pe128 

    Clearance and adverse effects of efavirenz are associated with CYP2B6-G516T polymorphism. Little is known about the prevalence of genotypes and implications for screening in children. We report (to our knowledge, for the first time in a child) the emergence of psychosis in a 12-year old white...


Read the Article


Sign out of this library

Other Topics